- Brand name
- Femular Tablets
- Active ingredient
- Cimicifuga racemosa rhizome dry
Consumer medicine information (CMI) leaflet
Please read this leaflet carefully before you start using Femular Tablets.Download CMI (PDF) Download large text CMI (PDF)
What is in this leaflet?
The information in this leaflet will answer some of the questions you may have about Femular tablets.
What Femular tablets are used for
Femular tablets are recommended for the relief of menopausal symptoms such as hot flushes, sweating, sleep disorders and nervous irritability.
Known hypersensitivity to Black cohosh or to any of the tablet ingredients.
How to take Femular tablets
Femular tablets are taken one tablet daily.
The onset of action can be expected within 2-4 weeks with a maximal effect felt within 3 months. There is no restriction on the duration of treatment. If symptoms persist, medical advice should be sought.
Special warnings and precautions for use
None required. Femular is only used by women with menopausal symptoms, it is not intended to be used during pregnancy and lactation.
Interaction with other medicines
Occasional gastrointestinal disturbances have been reported.
No cases of overdose have been reported.
Femular tablets should be stored in their original packaging, be protected from moisture and sunlight and kept in a cool place that stays below 25°C.
Each Femular tablet contains extracts equivalent to dry:
- Cimicifuga racemosa rhizome 42.25mg
Femular tablets contain lactose.
Femular is made in Switzerland by Zeller AG and is marketed by
Level 5, 156 Pacific Highway
St. Leonards NSW 2065 Australia
Telephone: 02 9431 7200
Fax: 02 9431 7272
Adapted from 41919 11/2005A